AREV Life Sciences Global Corporation announces engagement of TransBIOTech to facilitate preclinical therapeutic pipeline development
AREV Life Sciences Global Corporation announces engagement of TransBIOTech to facilitate preclinical therapeutic pipeline development
Arev生命科学全球公司宣布与TransBIOTech公司合作，促进临床前治疗流水线的开发
VANCOUVER, BC / TheNewswire / April 21, 2022 / AREV Life Sciences Global Corp. (CSE:AREV) (OTC:AREVF) ("AREV" or the "Company") AREV announced today its initial research engagement with TransBIOTech.
卑诗省温哥华/The Newswire/四月21, 2022 / Arev生命科学全球公司(CSE：ARREV)(场外交易代码：AREVF)("阿雷夫“或 "公司") Arev今天宣布其与TransBIOTech公司的初步研究合作。
Created in 1999, TransBIOTech, a publicly-supported preclinical research organization that works in partnership with and is supported by the Canadian government through the Natural Sciences and Engineering Research Council (NSERC) in collaboration with the Canadian Institutes of Health Research (CIHR). TransBIOTech is also supported by the Canadian Foundation for Innovation and by the Government of Quebec. TransBIOTech is a member of Tech-Access Canada, a national organization of Technology Access Centres (TACs) as well...
TransBIOTech成立于1999年，是一家公共支持的临床前研究组织，通过自然科学和工程研究理事会(NSERC)与加拿大卫生研究院(CIHR)合...
登录免费看全文
登录/注册